Latest Breaking News On - Claude bertrand - Page 1 : comparemela.com

MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting

Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing

Karim dabbaghJean marie lefebvreJean volatierBpifrance investissementNadia kamalKepler cheuvreuxClaude bertrandSenior pr corporate communicationsCompany universal registration documentTrophic communicationsRegulatory newsMicrobiome ecosystemExtraordinary general meetingSeventure partnersChief executive officerAnnual general meeting

FDA Accepts Application, Grants Priority Review to Vorasidenib for IDH-Mutant Diffuse Glioma

If vorasidenib receives full approval, it would be a first-in-class target therapy to treat individuals with IDH-mutant gliomas.

Susan pandyaClaude bertrandEuropean medicine agencyResearch developmentNew drug applicationPriority reviewPrescription drug unser fee actCancer metabolism global development oncologyHazard ratioConfidence intervalExecutive vice presidentChief scientific officer

FDA and EMA Accept Regulatory Submissions for Vorasidenib for IDH-Mutant Diffuse Glioma

Vorasidenib has been granted regulatory submission acceptance by the FDA and EMA for IDH-mutant diffuse glioma.

Claude bertrandSusan pandyaEuropean commissionCancer metabolism global development oncology immunoMeeting of the society for neuroEuropean medicines agencyResearch developmentMarketing authorization applicationNew england journalCancer metabolism global development oncologyPrescription drug user fee actIdh mutant diffuse glioma

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomFrance generalPrnewswire servierSusan pandyaNathan mellorClaude bertrandEuropean medicines agencyCommittee for medicinal products humanResearch developmentEuropean commissionEuropean unionNational comprehensive cancer network incServier group globalNational clinical practice guidelines in oncologyServier pharmaceuticals

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

/PRNewswire/ Servier, a global leader in oncology focused on delivering meaningful therapeutic progress for the patients it serves, today announced the FDA.

France generalUnited kingdomUnited statesSusan pandyaNathan mellorPrnewswire servierClaude bertrandNational clinical practice guidelines in oncologyServier group globalMeeting of the society for neuroServier pharmaceuticalsEuropean medicines agencyServier groupResearch developmentDrug administrationAccess program